soon as possible for treatment, while paying
attention to keeping the environment quiet and
providing adequate drinking water.
4.3 Severe Acute Allergic Reactions
It is rare, often occurring within 15 minutes after
injection of the vaccine, and severe allergic
symptoms occur a few seconds after injection of the
vaccine. The main symptoms are: allergic animals
suddenly fall to the ground, general weakness;
dyspnea, salivation, pale conjunctiva, systemic
cyanosis, decreased body temperature; systemic
muscle tremor, confusion, ataxia, incontinence,
unresponsiveness to various stimuli; severe cases
may develop anaphylactic shock, which can cause
death if not timely rescued (Ecuru, 2010).
For severe acute allergic reactions, epinephrine
injection should be performed immediately for
treatment, and some adjuvant therapy can be taken if
necessary.
5 PREVENTIVE MEASURES
Establish a reasonable immunization schedule to
avoid simultaneous immunization with other
vaccines and minimize the occurrence of stress
reactions to foot-and-mouth disease vaccines.
Before immunization, disinfection and sterilization
of devices should be done well, and drugs such as
epinephrine or glucocorticoids should be prepared at
the same time in order to treat allergic pigs timely.
During the immunization, operate in accordance
with the specifications strictly, inject according to
the dose specified in the instructions, and postpone
the immunization for the thin, pregnant animals with
a history of allergy. After the completion of vaccine
injection, attention should be paid to observation. If
allergic reactions occurred, contact the professionals
to take treatment measures as soon as possible. In
addition, establish immunization archives timely. In
case of any death of animals due to allergic reaction,
relevant personnel shall be contacted for harmless
treatment immediately.
6 CONCLUSION
The globalization of commerce is accelerating the
spread of FMDV and presents new requirements on
the trade of animals and animal productions. But
novel vaccines against FMDV are developed slowly,
and only few available novel FMD vaccines have
been used in practice. In the development of new
vaccines, we should improve the effectiveness while
give attention to safety, minimize allergic reactions
and reduce the physical discomfort and death of
animals caused by vaccination.
REFERENCES
Alexandersen, S., Mowat, N., 2005. Foot-and-mouth
disease: host range and pathogenesis, Current Topics
in Microbiology and Immunology, 288, 9–42.
Arztl, J., Juleff, N., Zhang, Z. and Rodriguez, L. L., 2011.
The pathogenesis of Foot-and-mouth disease I: viral
pathways in cattle, Transboundary and Emerging
Diseases. 58, 291–304.
Ayebazibwe, C., Tjørnehøj, K., Mwiine, F. N.,
Muwanika, V. B., Ademun, O. A. R., Siegismund, H.
R., Alexandersen, S., 2010a. Patterns, risk factors and
characteristics of reported and perceived foot-and-
mouth disease (FMD) in Uganda, Tropical Animal
Health and Production, 42(7), 1547–1559.
Belsham, J. G., Jamal, S. M., Tjørnehøj, K., Bøtner, A.,
2011. Rescue of Foot-and-Mouth Disease Viruses that
are Pathogenic for Cattle from Preserved Viral RNA
Samples. PLoS ONE, 6(1), e14621.
Doel, T. R., 2003. FMD Vaccines, Virus Research, 91,
81–99.
Ecuru, J. and Naluyima, H., 2010. Biotechnology
developments in Uganda and associated challenges,
African Crop Science Journal, 18 (4), 133–139.